JP2019519529A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019519529A5 JP2019519529A5 JP2018561669A JP2018561669A JP2019519529A5 JP 2019519529 A5 JP2019519529 A5 JP 2019519529A5 JP 2018561669 A JP2018561669 A JP 2018561669A JP 2018561669 A JP2018561669 A JP 2018561669A JP 2019519529 A5 JP2019519529 A5 JP 2019519529A5
- Authority
- JP
- Japan
- Prior art keywords
- car
- seq
- nos
- domain comprises
- antigen binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022089863A JP2022130396A (ja) | 2016-05-27 | 2022-06-01 | Ｆｌｔ３特異的なキメラ抗原受容体及びそれを使用する方法 |
| JP2024112931A JP2024156707A (ja) | 2016-05-27 | 2024-07-12 | Ｆｌｔ３特異的なキメラ抗原受容体及びそれを使用する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662342394P | 2016-05-27 | 2016-05-27 | |
| US62/342,394 | 2016-05-27 | ||
| PCT/US2017/034691 WO2017205747A1 (en) | 2016-05-27 | 2017-05-26 | Flt3-specific chimeric antigen receptors and methods using same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022089863A Division JP2022130396A (ja) | 2016-05-27 | 2022-06-01 | Ｆｌｔ３特異的なキメラ抗原受容体及びそれを使用する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019519529A JP2019519529A (ja) | 2019-07-11 |
| JP2019519529A5 true JP2019519529A5 (https=) | 2020-07-09 |
Family
ID=59054226
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018561669A Pending JP2019519529A (ja) | 2016-05-27 | 2017-05-26 | Ｆｌｔ３特異的なキメラ抗原受容体及びそれを使用する方法 |
| JP2022089863A Pending JP2022130396A (ja) | 2016-05-27 | 2022-06-01 | Ｆｌｔ３特異的なキメラ抗原受容体及びそれを使用する方法 |
| JP2024112931A Pending JP2024156707A (ja) | 2016-05-27 | 2024-07-12 | Ｆｌｔ３特異的なキメラ抗原受容体及びそれを使用する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022089863A Pending JP2022130396A (ja) | 2016-05-27 | 2022-06-01 | Ｆｌｔ３特異的なキメラ抗原受容体及びそれを使用する方法 |
| JP2024112931A Pending JP2024156707A (ja) | 2016-05-27 | 2024-07-12 | Ｆｌｔ３特異的なキメラ抗原受容体及びそれを使用する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11299546B2 (https=) |
| EP (2) | EP4413999A3 (https=) |
| JP (3) | JP2019519529A (https=) |
| AU (1) | AU2017271606B2 (https=) |
| CA (1) | CA3025516A1 (https=) |
| WO (1) | WO2017205747A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3025516A1 (en) * | 2016-05-27 | 2017-11-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Flt3-specific chimeric antigen receptors and methods using same |
| EP4714966A2 (en) | 2017-09-26 | 2026-03-25 | Cero Therapeutics Holdings, Inc. | Chimeric engulfment receptor molecules and methods of use |
| EP3774906A1 (en) | 2018-03-28 | 2021-02-17 | Cero Therapeutics, Inc. | Chimeric tim4 receptors and uses thereof |
| MX2020010241A (es) | 2018-03-28 | 2020-10-16 | Cero Therapeutics Inc | Composiciones de inmunoterapia celular y usos de las mismas. |
| SG11202104352XA (en) | 2018-12-18 | 2021-05-28 | Boehringer Ingelheim Io Canada Inc | Flt3 agonist antibodies and uses thereof |
| WO2020210719A1 (en) * | 2019-04-10 | 2020-10-15 | Elevatebio Management, Inc. | Flt3-specific chimeric antigen receptors and methods of using the same |
| TW202110873A (zh) | 2019-04-30 | 2021-03-16 | 美商聖堤生物科技股份有限公司 | 嵌合受體及其使用方法 |
| US20210253696A1 (en) * | 2020-01-21 | 2021-08-19 | Cero Therapeutics, Inc. | Bivalent chimeric engulfment receptors and uses thereof |
| US20230174614A1 (en) * | 2020-04-30 | 2023-06-08 | Terry J FRY | Multispecific anti-flt3 chimeric antigen receptors |
| CN116410315A (zh) * | 2021-12-31 | 2023-07-11 | 博生吉医药科技(苏州)有限公司 | 一种新型靶向人flt3的嵌合抗原受体修饰的t细胞的构建及应用 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3854480A (en) | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
| US3832253A (en) | 1973-03-21 | 1974-08-27 | Baxter Laboratories Inc | Method of making an inflatable balloon catheter |
| US4450150A (en) | 1973-05-17 | 1984-05-22 | Arthur D. Little, Inc. | Biodegradable, implantable drug delivery depots, and method for preparing and using the same |
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4667014A (en) | 1983-03-07 | 1987-05-19 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists |
| US4452775A (en) | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| CA1200416A (en) | 1983-05-13 | 1986-02-11 | Societe Des Produits Nestle S.A. | Food process |
| US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| IN165717B (https=) | 1986-08-07 | 1989-12-23 | Battelle Memorial Institute | |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| ATE158021T1 (de) | 1990-08-29 | 1997-09-15 | Genpharm Int | Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper |
| JPH04167172A (ja) | 1990-10-31 | 1992-06-15 | Nec Corp | ベクトルプロセッサ |
| JP3266311B2 (ja) | 1991-05-02 | 2002-03-18 | 生化学工業株式会社 | 新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤 |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| US6265150B1 (en) | 1995-06-07 | 2001-07-24 | Becton Dickinson & Company | Phage antibodies |
| US5714352A (en) | 1996-03-20 | 1998-02-03 | Xenotech Incorporated | Directed switch-mediated DNA recombination |
| WO2001058479A1 (en) | 2000-02-08 | 2001-08-16 | The Penn State Research Foundation | Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| US20130266551A1 (en) * | 2003-11-05 | 2013-10-10 | St. Jude Children's Research Hospital, Inc. | Chimeric receptors with 4-1bb stimulatory signaling domain |
| AR071891A1 (es) * | 2008-05-30 | 2010-07-21 | Imclone Llc | Anticuerpos humanos anti-flt3 (receptor tirosina cinasa 3 tipo fms humano) |
| PH12013501201A1 (en) * | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| RU2766608C2 (ru) | 2012-04-11 | 2022-03-15 | Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез | Химерные антигенные рецепторы, нацеленные на антиген созревания b-клеток |
| WO2014164544A1 (en) * | 2013-03-09 | 2014-10-09 | Baylor College Of Medicine | Vascular-targeted t-cell therapy |
| CA2932424C (en) | 2013-12-06 | 2023-10-10 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Thymic stromal lymphopoietin receptor-specific chimeric antigen receptors and methods using same |
| US20170335281A1 (en) * | 2014-03-15 | 2017-11-23 | Novartis Ag | Treatment of cancer using chimeric antigen receptor |
| TWI719942B (zh) * | 2014-07-21 | 2021-03-01 | 瑞士商諾華公司 | 使用ｃｄ３３嵌合抗原受體治療癌症 |
| WO2016075612A1 (en) * | 2014-11-12 | 2016-05-19 | Rinat Neuroscience Corp. | Inhibitory chimeric antigen receptors |
| EP3569244A1 (en) * | 2015-09-23 | 2019-11-20 | CytoImmune Therapeutics, LLC | Flt3 directed car cells for immunotherapy |
| KR20230148844A (ko) * | 2016-03-29 | 2023-10-25 | 유니버시티 오브 써던 캘리포니아 | 암을 표적하는 키메라 항원 수용체 |
| US11768203B2 (en) * | 2016-03-31 | 2023-09-26 | University Of Southern California | Highly sensitive and specific luciferase based reporter assay for antigen detection |
| CA3025516A1 (en) * | 2016-05-27 | 2017-11-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Flt3-specific chimeric antigen receptors and methods using same |
| US20230174614A1 (en) * | 2020-04-30 | 2023-06-08 | Terry J FRY | Multispecific anti-flt3 chimeric antigen receptors |
-
2017
- 2017-05-26 CA CA3025516A patent/CA3025516A1/en active Pending
- 2017-05-26 EP EP24167685.7A patent/EP4413999A3/en active Pending
- 2017-05-26 JP JP2018561669A patent/JP2019519529A/ja active Pending
- 2017-05-26 AU AU2017271606A patent/AU2017271606B2/en active Active
- 2017-05-26 EP EP17729627.4A patent/EP3464366A1/en active Pending
- 2017-05-26 WO PCT/US2017/034691 patent/WO2017205747A1/en not_active Ceased
- 2017-05-26 US US16/304,552 patent/US11299546B2/en active Active
-
2022
- 2022-03-08 US US17/689,698 patent/US12202902B2/en active Active
- 2022-06-01 JP JP2022089863A patent/JP2022130396A/ja active Pending
-
2024
- 2024-07-12 JP JP2024112931A patent/JP2024156707A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019519529A5 (https=) | ||
| JP2018531014A5 (https=) | ||
| FI3946621T3 (fi) | Mage a4 -t-solureptoreja | |
| JP2022109953A5 (https=) | ||
| JP2016502512A5 (https=) | ||
| JP2020519298A5 (https=) | ||
| EP4282878A3 (en) | Chimeric antigen receptors targeting bcma and methods of use thereof | |
| JP2017537622A5 (https=) | ||
| RU2015117237A (ru) | Химерные антигенные рецепторы м971 | |
| JP2012136541A5 (https=) | ||
| JP2016538830A5 (https=) | ||
| JP2019506841A5 (https=) | ||
| JP2020517635A5 (https=) | ||
| JP2017513478A5 (https=) | ||
| JP2014534207A5 (https=) | ||
| JP2022527635A5 (https=) | ||
| JP2018505139A5 (https=) | ||
| JP2016520074A5 (https=) | ||
| RU2018107802A (ru) | Полностью человеческие антитела к мезотелину и иммунные эффекторные клетки, нацеленные на мезотелин | |
| JP2018504145A5 (https=) | ||
| JP2017526361A5 (https=) | ||
| JP2017528158A5 (https=) | ||
| JP2019530431A5 (https=) | ||
| JP2019527557A5 (https=) | ||
| JP2016539096A5 (https=) |